Afinida Inc (TREP)

Afinida, Inc. (OTC: TREP) is a common stock listing of a company that, through its subsidiaries, provides outsourced business services in the United States. Its service portfolio includes payroll and tax administration, human resources management, employee benefits, accounting support, safety and risk management, as well as marketing and technology assistance for business clients. The company also provides commercial, business, and individual insurance solutions. Based in Escondido, California, Afinida was formerly known as Trucept, Inc. and adopted its current name in June 2025.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Overall Financial Health Dividend Yield Next Earnings Date Price-to-Book Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Free Cash Flow / Net Income
OTC-TREP
$0.020
34.7% Upside
Undervalued
Not available
Not available
Weak
0.0%
November 13, 2026
6.7x
841.476 K
955.391 K
18.0%
60.6%
1.4
1,197.0%
Valuation • Fair Value

Afinida Inc (OTC-TREP) Fair Value by Valuation Model

Review the available estimates for Afinida Inc (OTC-TREP), including Comps Fair Value.

Primary Valuation Read

Fair Value

$0.020

Estimated upside of 34.7% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

Comps Fair Value

$0.020

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use the 3 available valuation references for Afinida Inc (OTC-TREP) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Afinida Inc (OTC-TREP)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

22.643 M

Current operating scale indicator.

Revenue Forecast

27.591 M

Forward revenue estimate.

EBITDA

-564.465 K

Current operating profitability reference.

EBITDA Forecast

4.274 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Afinida Inc (OTC-TREP) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Afinida Inc (OTC-TREP)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Weak

Financial pressure deserves closer review.

Piotroski Score

1

Weak quality score that deserves closer review.

Beneish M-Score

5.36

Higher caution zone on this screen.

Altman Z-Score

1.4

Lower score that deserves closer risk review.

FCF / Net Income

1,197.0%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Afinida Inc (OTC-TREP). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Afinida Inc (OTC-TREP)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

November 13, 2026

Days to Earnings

52

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

This section helps investors track time-sensitive items for Afinida Inc (OTC-TREP), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Technical Outlook

Technical Signals by Time Frame

Review the technical signals currently available for this stock across supported time frames.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for Afinida Inc (OTC-TREP) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Afinida Inc (OTC-TREP) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Afinida Inc (OTC-TREP) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Afinida Inc (OTC-TREP) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Afinida Inc (OTC-TREP) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

FAQ Fast Investor Answers

Afinida Inc (OTC-TREP) Stock FAQ

Data-supported answers about Afinida Inc (OTC-TREP), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$0.020
Estimated upside 34.7%
Valuation Rating
Undervalued
Estimated upside of 34.7%
Financial Health
Weak
Current financial-health read

The current fair value estimate for Afinida Inc (OTC-TREP) is $0.020. This implies an estimated upside of 34.7% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 34.7% versus the current market price.

The current financial health read for Afinida Inc (OTC-TREP) is Weak. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Afinida Inc (OTC-TREP) is November 13, 2026.

The latest available data indicates no current dividend yield for Afinida Inc (OTC-TREP).

The current market capitalization listed for Afinida Inc is 841.476 K.

The current enterprise value listed for Afinida Inc is 955.391 K. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Afinida Inc is OTC-TREP, and the stock is listed on OTC Markets.

Afinida Inc (OTC-TREP) is listed on OTC Markets.

The current debt-to-total-capital ratio listed for Afinida Inc is 18.0%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Afinida Inc is 60.6%. Free float helps investors understand how much of the share base is available for public trading.